OpenBilldrug price receipt

NADAC week of 2026-10-14

FLUVOXAMINE ER 100 MG CAPSULE

For 30 capsules

Pharmacies pay

$122.33 filed

30 × $4.07757 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$179.26 filed

30 × $5.97541 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.5× estimated

Medicare paid 1.5× what pharmacies pay.

Part D averages every strength and form sold under “Fluvoxamine Maleate ER” / “Fluvoxamine Maleate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$145.68 estimated

$122.33 + $18.35 (15%) + $5.00 fee per fill = $145.68

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FLUVOXAMINE ER 100 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “fluvoxamine maleate” and “fluvoxamine maleate extended-release”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as capsule, extended release and its route as oral.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Par Health USA, LLC and Ajanta Pharma USA Inc.

FDA’s Established Pharmacologic Class for it is Serotonin Reuptake Inhibitor.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $122.33 for 30 capsules (30 × $4.07757 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 6 NDCs

Other strengths, forms and brands

4 other products in the NADAC file share an FDA nonproprietary name with FLUVOXAMINE ER 100 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
FLUVOXAMINE ER 100 MG CAPSULE this page
generic · capsule, extended release
$4.07757 per EA filed
eff. 2026-09-23 to 2026-10-07
$5.97541 per EA filed
Part D 2024 average
FLUVOXAMINE ER 150 MG CAPSULE
generic · capsule, extended release
$3.97362 per EA filed
eff. 2026-09-23 to 2026-10-07
$5.97541 per EA filed
Part D 2024 average
FLUVOXAMINE MALEATE 25 MG TAB
generic · tablet / tablet, film coated / tablet, coated
$0.15136 per EA filed
eff. 2026-09-23
$0.65763 per EA filed
Part D 2024 average
FLUVOXAMINE MALEATE 50 MG TAB
generic · tablet / tablet, film coated / tablet, coated
$0.19537 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.65763 per EA filed
Part D 2024 average
FLUVOXAMINE MALEATE 100 MG TAB
generic · tablet / tablet, film coated / tablet, coated
$0.24481 per EA filed
eff. 2026-09-23
$0.65763 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $4.07757 per EA filed.

Of the 58 other products in FDA’s Serotonin Reuptake Inhibitor class priced per EA, 18 have a higher middle NADAC price and 40 a lower one. The one in the middle is PAROXETINE ER 37.5 MG TABLET, at $0.3974 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $179.26 for 30 capsules, at an average of $5.97541 per EA in 2024 (2024-01-01 to 2024-12-31) for “Fluvoxamine Maleate ER” and “Fluvoxamine Maleate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 17,787 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FLUVOXAMINE ER 100 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Fluvoxamine Maleate ER / Fluvoxamine Maleate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.